Skip to main content
. 2014 Nov 12;2014:564573. doi: 10.1155/2014/564573

Table 3.

Dose (1, 4, and 8 mg/kg/day of AmB) related in vivo hematological responses of prepared formulations against marketed and reference drug.

Parameters Doses (mg/kg/day) Std. drug sol. Fungizone Ambisome CS-AMB CS-POR-AMB CS-POR-AMB-TPP Control Blank
RBCs (×106/μL) 1 5.21 ± 0.3 5.77 ± 0.2 6.16 ± 1.3 6.18 ± 1.8 7.12 ± 1.5 7.08 ± 0.27 7.96 ± 1.8 8.12 ± 1.2
4 4.11 ± 1.2 4.81 ± 1.3 5.21 ± 1.1 5.53 ± 1.7 6.78 ± 1.8 6.31 ± 1.6
8 3.71 ± 1.1 4.07 ± 1.3 4.14 ± 0.3 4.11 ± 0.41 5.72 ± 1.2 5.22 ± 1.0

WBCs (×103/μL) 1 4.7 ± 0.3 5.1 ± 1.6 6.0 ± 1.1 5.9 ± 1.4 6.2 ± 0.7 5.8 ± 1.6 6.2 ± 1.1 5.9 ± 0.2
4 4.4 ± 1.3 4.6 ± 1.3 5.5 ± 1.4 5.7 ± 0.6 5.7 ± 1.2 5.3 ± 0.1
8 3.8 ± 0.8 4.8 ± 1.7 5.1 ± 1.8 4.9 ± 0.3 5.4 ± 1.1 5.2 ± 0.2

PL (×103/μL) 1 134 ± 23 178 ± 11 275 ± 18 281 ± 26 389 ± 41 371 ± 33 372 ± 21 433 ± 33
4 106 ± 28 144 ± 27 239 ± 23 237 ± 1.3 274 ± 11 266 ± 23
8 92 ± 11 116 ± 13 191 ± 16 182 ± 12 211 ± 31 207 ± 17

HT (%) 1 30.2 ± 2.4 32.1 ± 2.2 35.2 ± 3.1 34.1 ± 2.8 38.7 ± 3.4 38.2 ± 2.4 42.1 ± 3.1 41.1 ± 2.7
4 28.1 ± 3.1 30.7 ± 1.1 33.5 ± 2.1 31.1 ± 1.9 36.6 ± 3.1 35.2 ± 3.3
9 26.1 ± 2.5 29.1 ± 2.6 30.2 ± 1.7 29.1 ± 2.3 35.1 ± 1.7 34.1 ± 1.8

Hb (g/dL) 1 12.1 ± 1.3 13.2 ± 0.3 13.8 ± 0.2 13.3 ± 0.5 14.6 ± 3.2 14.3 ± 1.2 15.2 ± 1.4 15.1 ± 1.2
6 11.2 ± 1.1 12.4 ± 1.4 12.6 ± 1.6 12.1 ± 1.8 13.7 ± 0.3 13.6 ± 1.6
9 10.3 ± 0.2 11.1 ± 0.2 11.8 ± 0.1 11.7 ± 1.2 12.8 ± 1.3 12.7 ± 0.1

RBCs (red blood cells); WBCs (white blood cells); Hb (hemoglobin); PL (platelet); HT (hematocrit).

Significant (P < 0.05, all groups compared with control). n = 6 in each group. Values are expressed as mean ± S.E.M. Data was analyzed by one-way ANOVA followed by Tukey's post hoc test.